LODESTAR INVESTMENT COUNSEL LLC/IL - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,046 filers reported holding BAXTER INTL INC in Q4 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
LODESTAR INVESTMENT COUNSEL LLC/IL ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2019$1,142,000
-1.4%
13,939
-2.1%
0.12%
-5.6%
Q1 2019$1,158,000
+23.6%
14,2390.0%0.12%
+8.8%
Q4 2018$937,000
-20.7%
14,239
-7.2%
0.11%
-10.9%
Q3 2018$1,182,000
-2.6%
15,339
-6.7%
0.13%
-8.6%
Q2 2018$1,214,000
+13.6%
16,4390.0%0.14%
+12.0%
Q1 2018$1,069,000
+0.6%
16,4390.0%0.12%
+1.6%
Q4 2017$1,063,000
+2.7%
16,439
-0.3%
0.12%
-3.1%
Q3 2017$1,035,000
+4.3%
16,489
+0.6%
0.13%
+0.8%
Q2 2017$992,000
+16.2%
16,389
-0.5%
0.13%
+13.5%
Q1 2017$854,000
+13.9%
16,464
-2.6%
0.11%
+9.9%
Q4 2016$750,000
-8.6%
16,904
-2.0%
0.10%
-10.6%
Q3 2016$821,000
+6.5%
17,254
+1.2%
0.11%
+2.7%
Q2 2016$771,000
-9.6%
17,054
-17.8%
0.11%
-10.6%
Q1 2016$853,000
-67.1%
20,754
-69.4%
0.12%
-69.9%
Q4 2015$2,590,000
+16.0%
67,880
-0.1%
0.41%
+9.1%
Q3 2015$2,232,000
-53.5%
67,930
-1.1%
0.38%
-50.3%
Q2 2015$4,803,000
+3.6%
68,680
+1.5%
0.76%
+5.4%
Q1 2015$4,637,000
+2.2%
67,690
+9.4%
0.72%
-44.8%
Q4 2014$4,537,000
+16.7%
61,900
+14.3%
1.30%
+9.2%
Q3 2014$3,888,000
+6.9%
54,175
+7.7%
1.19%
+8.7%
Q2 2014$3,637,000
+10.0%
50,300
+11.9%
1.09%
+5.4%
Q1 2014$3,307,000
+6.1%
44,950
+0.3%
1.04%
+2.6%
Q4 2013$3,116,00044,8001.01%
Other shareholders
BAXTER INTL INC shareholders Q4 2017
NameSharesValueWeighting ↓
Third Point 36,000,000$2,658,240,00018.52%
SECTOR GAMMA AS 721,058$53,243,0008.85%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,747,061$202,843,0005.38%
Veritas Asset Management LLP 8,852,005$653,632,0005.36%
Knowledge Leaders Capital, LLC 79,384$5,862,0004.39%
HealthCor Management, L.P. 1,800,000$132,912,0004.22%
Progressive Investment Management Corp 79,282$5,854,0003.78%
13D Management LLC 200,318$14,791,0003.77%
ARGENT CAPITAL MANAGEMENT LLC 1,288,236$95,123,0003.42%
Chiron Investment Management, LLC 612,787$45,248,0003.12%
View complete list of BAXTER INTL INC shareholders